Novartis AG Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

10,658.44

11,130.24

11,620.87

11,896.11

11,540.46

11,110.53

11,316.24

Other Operating Income

0.00

Total Operating income

10,658.44

11,130.24

11,620.87

11,896.11

11,540.46

11,110.53

11,316.24

Raw Material Cost

2,830.85

2,828.77

2,744.39

2,900.99

2,916.48

2,809.91

2,869.76

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

242.96

224.86

238.97

242.72

241.29

228.74

222.49

Selling and Distribution Expenses

2,746.13

2,643.92

2,845.27

2,749.06

3,071.78

2,715.46

2,795.60

Other Expenses

202.44

206.70

192.41

188.33

199.35

183.25

187.58

Total Expenditure (Excl Depreciation)

7,844.37

7,764.52

7,752.76

7,776.12

8,223.01

7,586.66

7,763.64

Operating Profit (PBDIT) excl Other Income

2814.1000000000004

3365.7

3868.1

4120

3317.5

3523.8999999999996

3552.6

Other Income

423.59

291.28

416.74

131.25

328.15

421.96

294.84

Operating Profit (PBDIT)

4,477.25

4,664.47

5,244.03

5,285.06

5,074.01

5,648.41

4,898.40

Interest

242.96

224.86

238.97

242.72

241.29

228.74

222.49

Exceptional Items

-421.19

-71.22

-296.85

-44.05

-519.42

-780.67

-149.23

Gross Profit (PBDT)

7,827.59

8,301.47

8,876.48

8,995.12

8,623.98

8,300.62

8,446.48

Depreciation

1,239.59

1,007.48

959.17

1,033.82

1,428.41

1,702.58

1,050.95

Profit Before Tax

2,573.50

3,360.92

3,749.04

3,964.47

2,884.90

2,936.41

3,475.73

Tax

650.57

212.86

419.22

717.38

407.99

173.29

538.14

Provisions and contingencies

0.00

Profit After Tax

1,925.33

3,143.26

3,341.39

3,241.70

2,472.52

2,763.12

2,935.78

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,925.33

3,143.26

3,341.39

3,241.70

2,472.52

2,763.12

2,935.78

Share in Profit of Associates

0.00

Minority Interest

-4.00

1.60

-14.06

2.70

1.75

-3.47

0.00

Other related items

0.00

Consolidated Net Profit

1,921.33

3,144.86

3,327.34

3,244.39

2,474.27

2,759.65

2,935.78

Equity Capital

0.00

Face Value

0.0

Reserves

36,546.49

35,271.16

33,420.06

33,946.97

39,916.69

36,540.06

37,501.27

Earnings per share (EPS)

1.0

1.62

1.7

1.64

1.23

1.36

1.43

Diluted Earnings per share

1.0

1.62

1.7

1.64

1.23

1.36

1.43

Operating Profit Margin (Excl OI)

26.4%

30.24%

33.29%

34.63%

28.75%

31.72%

31.39%

Gross Profit Margin

35.78%

39.25%

40.52%

42.02%

37.38%

41.75%

40.0%

PAT Margin

18.06%

28.24%

28.75%

27.25%

21.42%

24.87%

25.94%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is -4.24% vs -4.22% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -38.91% vs -5.48% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -7.31% vs -9.41% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 8.05% vs -5.90% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Novartis AG With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(CHF)

Change(%)

Net Sales

10,658.44

Other Operating Income

0.00

Total Operating income

10,658.44

Raw Material Cost

2,830.85

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

242.96

Selling and Distribution Expenses

2,746.13

Other Expenses

202.44

0.00

202.44

Total Expenditure (Excl Depreciation)

7,844.37

Operating Profit (PBDIT) excl Other Income

2,814.06

0.00

2,814.06

Other Income

423.59

Operating Profit (PBDIT)

4,477.25

Interest

242.96

Exceptional Items

-421.19

Gross Profit (PBDT)

7,827.59

Depreciation

1,239.59

Profit Before Tax

2,573.50

Tax

650.57

Provisions and contingencies

0.00

Profit After Tax

1,925.33

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,925.33

Share in Profit of Associates

0.00

Minority Interest

-4.00

Other related items

0.00

Consolidated Net Profit

1,921.33

Equity Capital

0.00

Face Value

0.00

Reserves

36,546.49

Earnings per share (EPS)

1.00

Diluted Earnings per share

1.00

Operating Profit Margin (Excl OI)

26.40%

0.00

26.40%

Gross Profit Margin

35.78%

0.00

35.78%

PAT Margin

18.06%

0.00

18.06%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 1,065.84 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is -4.24% vs -4.22% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -7.64% vs 13.82% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 192.13 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is -38.91% vs -5.48% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -22.35% vs 5.67% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 405.37 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is -7.31% vs -9.41% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -14.59% vs 22.66% in Dec 2024

Quarterly - Interest

Interest 24.30 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 8.05% vs -5.90% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 0.70% vs 15.68% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 26.40%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024